A study to evaluate the knowledge of women about the prevention of carcinoma cervix by vaccination

Authors

  • Meher Sultana Department of Obstetrics and Gynaecology, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Tahmina Khan Shammi Department of Obstetrics and Gynaecology, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Sabina Akhter Department of Obstetrics and Gynaecology, Dhaka Medical College Hospital, Dhaka, Bangladesh
  • Farhana Ahmed Nancy Department of Obstetrics and Gynaecology, Dhaka Medical College Hospital, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20241422

Keywords:

Knowledge, Women prevention, Carcinoma cervix, HPV, Vaccination, EPI

Abstract

Background: Cervical cancer, characterized by malignant growth in the cervix uteri, often manifests with vaginal bleeding and can progress silently until reaching an advanced stage. It ranks as the most common cancer among women in numerous developing nations. The study aimed to evaluate the knowledge of the women about the prevention of carcinoma cervix by vaccination.

Methods: This cross-sectional observational study was conducted at the outpatient department of obstetrics and gynecology, Dhaka medical college and hospital, Bangladesh from Jan 2020 to Dec 2021. In this study, 100 women attending the mentioned department, were interviewed with a view in mind to find out their knowledge level regarding the vaccination of cervical cancers. Data were analyzed by using MS office tools.

Results: The study revealed a direct correlation between education level and awareness of HPV, underscoring a significant lack of knowledge about cervical cancer vaccination. It emphasizes the urgent need to educate individuals about the vaccine's role in preventing cervical cancer. Education campaigns utilizing local media could effectively disseminate information.

Conclusions: The unavailability and cost of the vaccine pose barriers to its accessibility. Integrating the vaccine program into existing expanded program on immunization (EPI) initiatives could be transformative for community health.

References

Smeltzer SC, Bare BG. Handbook for Brunner and Suddarths Textbook of Medical-Surgical Nursing 10th Edition. Philadelphia: Lippincott. 2004.

American Cancer Society. 2009. Available at. http://www.cancer.org/docroot/CRI/content242X. Accessed on 2 April, 2024.

Ndlovu BH. Awareness, knowledge, and experiences of women regarding cervical cancer in rural Kwazulu-Natal, South Africa. Diss. Stellenbosch: University of Stellenbosch. 2011.

Erstad Shannon. “Cone-biopsy (conization) for abnormal cervical cell changes”. Available at: http://www. webmd.com/ cancer/cervical-cancer/cone-biopsy-colonisation-froabnormal-cervical-cell-changes.https://en-academic.com/dic.nsf/enwiki/34025. Accessed on 2 April, 2024.

Adanu, R.M.K. Cervical Cancer Knowledge and Screening in Accra, Ghana. J Women’s Health Gender-Based Med. 2002;11(6):487-8.

Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality, and prevalence worldwide. IARC Cancer Base No. 5, version 2.0. IARC Press, Lyon, 2004. Available at: http://www-depdb.iarc.fr/globocan/GLOBOframe.htm. Accessed on 2 April, 2024.

Lowndes, Catherine M., and O. Noel Gill. "Cervical cancer, human papillomavirus, and vaccination. BMJ. 2005;331(7522):915-6.

Elfgren K, Kalantari M, Moberger B, Hagmar B, Dillner J. A population-based five-year follow-up study of cervical human papillomavirus infection. Am J Obstet Gynecol. 2000;183(3):561-7.

Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder A, Manos MM, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis. 2001;183(1):8-15.

Harper DM, Franco EL, Wheeler C, Daron GF, David J, Anne S, et al. GlaxoSmithKline HPV Vaccine Study Group. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet. 2004;364(9447):1757-65.

Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157:218-26.

Poole DN, Tracy JK, Levitz L, Rochas M, Sangare K, Yekta S, et al. A cross-sectional study to assess HPV knowledge and HPV vaccine acceptability in Mali. PLoS One. 2013;8(2):e56402.

Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, Soogun S, et al. A qualitative analysis of South African women’s knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine. 2011;29(47):8760-65.

Deriemaeker H, Michielsen D, Reichman G, Devroey D, Cammu H. Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students. Central European J Urol. 2014;67(4):410-17.

Blake KD, Ottenbacher AJ, Finney Rutten LJ, Grady MA, Kobrin SC, Jacobson RM, et al. Predictors of Human Papillomavirus Awareness and Knowledge in 2013: Gaps and Opportunities for Targeted Communication Strategies. Am J Prev Med. 2015;48(4):402-10.

Loots GG, Ovcharenko I. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res. 2004;32:W217-21.

Makwe CC, Anorlu RI, Odeyemi KA. Human papillomavirus (HPV) infection and vaccines: knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria. J Epidemiol Glob Heal. 2012;2(4):199-206.

Bigman CA, Cappella JN, Hornik RC. Effective or ineffective: attribute framing and the human papillomavirus (HPV) vaccine. Patient Educ Couns. 2010;81(1):S70-6.

Gerend MA, Shepherd JE. Using message framing to promote acceptance of the human papillomavirus vaccine. Health Psychol. 2007;26(6):745-52.

Francis SA, Nelson J, Liverpool J, Soogun S, Mofammere N, Thorpe JRJ, et al. Examining attitudes and knowledge about HPV and cervical cancer risk among female clinic attendees in Johannesburg, South Africa. Vaccine. 2010;28(50):8026-32.

Coleman MA, Levison J, Sangi-Haghpeykar H. HPV vaccine acceptability in Ghana, West Africa. Vaccine 2011;29:3945-50.

Wigle J, Coast E, Watson-Jones D. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects. Vaccine. 2013;31(37):3811-7.

Downloads

Published

2024-05-29

Issue

Section

Original Research Articles